Equities Analysts Offer Predictions for IRWD Q3 Earnings
3 Articles
3 Articles
Equities Analysts Offer Predictions for IRWD Q3 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research cut their Q3 2026 earnings per share estimates for shares of Ironwood Pharmaceuticals in a research note issued to investors on Monday, September 8th. Zacks Research analyst Team now expects that the biotechnology company will post earnings of $0.12 per share for the quarter, down […]
Research Analysts Offer Predictions for LULU Q3 Earnings
lululemon athletica inc. (NASDAQ:LULU – Free Report) – Investment analysts at KeyCorp issued their Q3 2026 earnings estimates for lululemon athletica in a report issued on Monday, September 8th. KeyCorp analyst A. Owens expects that the apparel retailer will earn $2.23 per share for the quarter. KeyCorp currently has a “Sector Weight” rating on the […]
Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Price Target at $4.94
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has been assigned an average recommendation of “Hold” from the seven brokerages that are presently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium